Showing results (161-170 of 1,917) with videos related to
Sort By:
Pageof 192
CNS & Neurological Disorders Drug Targets|April 26, 2018
The Underlying Role of Oxidative Stress in Neurodegeneration: A Mechanistic ReviewHabib Yaribeygi, Yunes Panahi, Behjat Javadi, et al.CNS & Neurological Disorders Drug Targets|April 26, 2018
Cerebrolysin and Aquaporin 4 Inhibition Improve Pathological and Motor Recovery after Ischemic StrokeBogdan Catalin, Otilia-Constantina Rogoveanu, Ionica Pirici, et al.CNS & Neurological Disorders Drug Targets|April 26, 2018
Clinical Observation of Electroencephalographic Changes and Risk of Convulsion Occurrence in Children Receiving Neural Precursor Cell TransplantationSuqing Qu, Weipeng Liu, Hui Yang, et al.CNS & Neurological Disorders Drug Targets|April 14, 2018
N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric DisordersMichelle Healy-Stoffel, Beth LevantCNS & Neurological Disorders Drug Targets|June 12, 2018
A Multi-targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal MotilityHua-Fu Zhao, Gang Wang, Chang-Peng Wu, et al.CNS & Neurological Disorders Drug Targets|April 26, 2017
Mitochondrial Permeability Transition Pore as a Suitable Targ e t for Neuroprotective Agents Against Alzheimer's DiseaseElena F Shevtsova, Daria V Vinogradova, Margarita E Neganova, et al.CNS & Neurological Disorders Drug Targets|April 3, 2022
Prospects for Neurotrophic Factor-Based Early Intervention in Schizophrenia: Lessons Learned from the Effects of Antipsychotic Drugs on Cognition, Neurogenesis, and Neurotrophic FactorsMohammad M Khan, Vinay ParikhCNS & Neurological Disorders Drug Targets|March 25, 2022
The Protective Effect of Vitexin Compound B-1 on Rat Cerebral I/R Injury through a Mechanism Involving Modulation of miR-92b/NOX4 PathwayZhong-Yang Hu, Zhong-Bao Yang, Ruxu Zhang, et al.CNS & Neurological Disorders Drug Targets|March 7, 2022
Gene Therapy for Neuropsychiatric Disorders: Potential Targets and ToolsSeyed H Shahcheraghi, Jamshid Ayatollahi, Marzieh Lotfi, et al.CNS & Neurological Disorders Drug Targets|January 22, 2021
Neurological Manifestations of COVID-19 and the Importance of Magnetic Resonance ImagingRubens J Gagliardi, Renan Domingues, Cristine Cukier, et al.Pageof 192